Serina Therapeutics Inc (SER) — Financial Flexibility Index
Serina Therapeutics Inc (SER) has a Financial Flexibility Index of -0.35x as of September 2025. Free cash flow of $-3.84 Million (operating CF $-3.85 Million minus capex $13.00K) represents 0% of total liabilities ($10.82 Million). Also explore Serina Therapeutics Inc equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Serina Therapeutics Inc Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Serina Therapeutics Inc across 9 annual periods. Check how strategically is Serina Therapeutics Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Serina Therapeutics Inc (2016–2024)
Year-by-year free cash flow to debt coverage for Serina Therapeutics Inc. For the full company profile including market capitalisation, see Serina Therapeutics Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.75x | $-17.11 Million | $-17.14 Million | $6.22 Million | ▼ -5661.2% |
| 2023 | -0.05x | $-1.97 Million | $-2.48 Million | $41.26 Million | ▲ +52.4% |
| 2022 | -0.10x | $-2.07 Million | $-2.08 Million | $20.56 Million | ▲ +29.5% |
| 2021 | -0.14x | $-2.14 Million | $-2.25 Million | $15.03 Million | ▲ +83.0% |
| 2020 | -0.84x | $-7.80 Million | $-7.82 Million | $9.32 Million | ▲ +57.6% |
| 2019 | -1.97x | $-9.52 Million | $-10.16 Million | $4.83 Million | ▲ +21.1% |
| 2018 | -2.50x | $-6.10 Million | $-8.00 Million | $2.44 Million | ▲ +47.8% |
| 2017 | -4.79x | $-6.28 Million | $-6.29 Million | $1.31 Million | ▼ -1358.9% |
| 2016 | -0.33x | $-8.40 Million | $-8.43 Million | $25.60 Million | — |